Containing HIV after infection

Nature Medicine

Volumn 6, Issue 10, 2000, Pages 1094-1095

  Walker, B D ^a   Rosenberg, E S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MACACA; PRIORITY JOURNAL; SHORT SURVEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

ANIMAL; ANTI-HIV AGENTS; HIV INFECTIONS; HUMAN; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIV; VIRAL VACCINES;

EID: 0033790883     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/80415     Document Type: Short Survey

References (15)

1. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
2. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
3. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
4. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
5. 251 infection of macaques
6. Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques
7. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
8. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
9. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
10. Changes in thymic function with age and during the treatment of HIV infection
11. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
12. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
13. Control of HIV despite the discontinuation of antiretroviral therapy
14. HIV-1-specific immune responses in subjects who temporarily conrain virus replication after discontinuation of highly active antiretroviral therapy
15. Viral immune evasion due to persistence of activated T cells without effector function